SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Gland Pharma

BSE: 543245 28 Jun 2025
Healthcare
₹ 1739
Gland Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Gland Pharma - Share Price & Details

Market Cap
₹28,394
High /Low
2,221 / 1,200
Stock P/E
40.6
Book Value
₹555.0
Dividend Yield
1.16
ROCE
11.9
ROE
₹7.82
Face Value
1.0
PEG Ratio
-24.3
EVEBITDA
₹17.6
Debt
314
CMP / FCF
67.6
Debt to equity
₹0.03
NP Ann
699
High price all time
4,350
Piotroski score
₹5.0
Graham Number
728.0
No. Eq. Shares
16.5
Net CF
₹2,186
Net profit
699
Price to book value
3.1
Interest Coverage
₹26.3
Low price all time
861.0
Industry PE
32.0
Reserves
₹9,134
Free Cash Flow
₹521

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Gland Pharma Limited10740.712899.9910303.5317.628,39440.6
J.B.CHEMICALS & PHARMACEUTICAL9148.71498.09013.49.442766341.9
PIRAMAL PHARMA LIMITED17293.12772.716898.02.0925934285.0

Peer Comparison Chart


About Gland Pharma

Gland Pharma Limited, with Security Code 543245, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Gland Pharma Ltd soars 0.15%, gains for fifth straight session

(10 Jun 2025)
Gland Pharma Ltd is quoting at Rs 1650.9, up 0.15% on the day as on 12:44 IST on the NSE. The stock is down 11.98% in last one year as...
Read more →

Pharma Stocks Rally: Granules India, Gland Pharma, Cipla Jump Up To 28% | Market Update

(06 Jun 2025)
Pharma stocks like Granules India, Gland Pharma, and Cipla surge up to 28% since April 2025. Discover key drivers, financial trends,...
Read more →

Missed the pharma rebound? Gland Pharma, Cipla among 8 stocks that jumped up to 28% since April

(06 Jun 2025)
Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index increasing 13%.
Read more →

Gland Pharma Gets USFDA Nod For Angiotensin II Acetate Injection

(05 Jun 2025)
Gland Pharma Limited, a leading generic injectable and ophthalmic-focused pharmaceutical company, has received approval from the United...
Read more →

Gland Pharma, SBFC Finance among 10 smallcap stocks where FIIs raised stake in Q4

(28 May 2025)
Foreign institutional investors (FIIs) increased their exposure to several small-cap stocks in the fourth quarter of FY25,...
Read more →

Gland Pharma Q4 FY25 PAT falls to Rs. 186.5 Cr

(26 May 2025)
Gland Pharma Ltd posted 3.1 per cent YoY drop in net profit for the quarter ended March 31, 2025 at Rs. 186.5 crore as against Rs. 192.4...
Read more →